TAZUR 4 g/500 mg
TAZUR 4g/500 mg I.V is used for the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisims...
View Details GX INTERNATIONAL, INC. has carried out its mission of providing Filipinos affordable medicines of the best quality.
This relentless and persistent drive has radiated to the medical community through the
years, allowing the Filipino patient to benefit quality healthcare.
"A vision to seek for options so that quality treatment may not have to be expensive."
- Rodolfo I. Gracia
GXI Founder
With sincere efforts to uplift the well-being of each Filipino patient, GXI dedicates itself to provide quality yet affordable medicines in the field of cardiovascular, metabolic, respiratory, infectious, inflammatory and acid-related diseases, considered as leading causes of morbidity and mortality.
Through the years, GXI was able to prove in the medical community that medicines can be made affordable without compromise of quality. Only the finest grade of raw materials and finished products from reputable international suppliers are considered.
GXI values its people as the prime movers of sustained growth. Guided by the corporate norms and values, the GXI field force remains true advocates of the company's noble mission to serve more Filipino patients, most especially the economically-challenged ones.
News and Updates
Zemiglo is the optimized DPP-IV Inhibitor, because of its five unique characteristics like Potent Efficacy, Stable Glycemic Control, Beyond Glycemic Control, Reliable Safety and Better Compliance.
On April 30, 2019, GXI inaugurated its own Corporate Center located in Buencamino St., Cupang, Muntinlupa City.
GXI's ATORVASTATIN (SAATIN) was introduced to the medical community with the Filipiniana inspired marketing.
In affiliation with: